Reported Reactions

Devices › Aortic valve, prosthesis, percutaneously delivered

Device brand name · Aortic valve prosthesis percutaneously delivered

Edwards Lifesciences SAPIEN 3 Transcatheter Heart Valve: medical device reports filed with FDA

266 reports name it, 2023–2026. Manufacturer given most often on reports: Edwards Lifesciences. Product code NPT.

266
device reports naming the brand
0% of all MAUDE reports · about 80 a year
132
reports, 12 months to August 2026
122 in the 12 months before
1.5%
classified as malfunction
15.2% across the product code
5.3%
classified as death, as reported
14 reports · not verified by FDA

FDA's MAUDE database holds 266 reports that name the brand "Edwards Lifesciences SAPIEN 3 Transcatheter Heart Valve" (aortic valve prosthesis percutaneously delivered), received between March 2023 and August 2026; the manufacturer given most often on reports is Edwards Lifesciences. Spellings of one product vary from report to report.

132 reports arrived in the 12 months to August 2026, close to the 122 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (93.2%), death (5.3%) and malfunction (1.5%); across all aortic valve, prosthesis, percutaneously delivered reports (product code NPT) death is recorded in 10.1% and malfunction in 15.2%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are calcified (29.3%), degraded (28.6%) and device stenosis (14.3%). The patient problems coded most often are dyspnea, heart failure/congestive heart failure and fatigue. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

01020Sep 2021: 0Oct 2021: 0Nov 2021: 0Dec 2021: 02022Jan 2022: 0Feb 2022: 0Mar 2022: 0Apr 2022: 0May 2022: 0Jun 2022: 0Jul 2022: 0Aug 2022: 0Sep 2022: 0Oct 2022: 0Nov 2022: 0Dec 2022: 02023Jan 2023: 0Feb 2023: 0Mar 2023: 4Apr 2023: 0May 2023: 1Jun 2023: 1Jul 2023: 1Aug 2023: 3Sep 2023: 0Oct 2023: 0Nov 2023: 0Dec 2023: 02024Jan 2024: 0Feb 2024: 0Mar 2024: 1Apr 2024: 1May 2024: 0Jun 2024: 0Jul 2024: 0Aug 2024: 0Sep 2024: 0Oct 2024: 5Nov 2024: 6Dec 2024: 142025Jan 2025: 10Feb 2025: 20Mar 2025: 12Apr 2025: 15May 2025: 8Jun 2025: 14Jul 2025: 6Aug 2025: 12Sep 2025: 11Oct 2025: 17Nov 2025: 10Dec 2025: 112026Jan 2026: 5Feb 2026: 7Mar 2026: 13Apr 2026: 9May 2026: 13Jun 2026: 16Jul 2026: 8Aug 2026: 12

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

0731462023: 1020232024: 2720242025: 14620252026: 832026

Event type and report source

Event type, as classified on the report

Death5.3%14
Injury93.2%248
Malfunction1.5%4
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%266
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 79,063 reports carrying product code NPT. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Calcified7829.3%2.8%
Degraded7628.6%3%
Device stenosis3814.3%2.9%
Perivalvular leak217.9%13%
Insufficient device problem information186.8%10.2%
Patient device interaction problem134.9%11.9%
Intravalvular regurgitation124.5%3%
Difficult to open or close103.8%1%
Gradient increase83%3.2%
Malposition of device83%5%
Migration or expulsion of device62.3%2.4%
Fluid/blood leak31.1%2.7%
Migrationthe device moved from where it was placed31.1%0.9%
Expulsion20.8%0%
Material deformation20.8%1.6%
Contamination10.4%0%
Material split, cut or torn10.4%1.2%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Dyspneashortness of breath6624.8%
Heart failure/congestive heart failure6122.9%
Fatiguetiredness103.8%
Heart block93.4%
Chest painchest pain62.3%
Cardiogenic shockshock from the heart failing to pump41.5%
Pericardial effusionfluid around the heart41.5%
Rupturethe device burst41.5%
Stroke/cva41.5%
Dizzinesslight-headedness or unsteadiness31.1%
Aortic dissection20.8%
Cardiac arrestthe heart stopped20.8%
Foreign body embolism20.8%
Presyncope20.8%
Abdominal painstomach or belly pain10.4%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureEdwards Lifesciences SAPIEN 3 Transcatheter Heart ValveProduct code NPTAll MAUDE reports
Reports26679,06326,136,888
Share of that pool—0.3%0%
Classified as death, per 1,000 reports531019
Classified as injury93.2%74.6%36.2%
Classified as malfunction1.5%15.2%62.3%
Filed by the manufacturer100%99.6%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code NPT

BrandReportsLatest 12 monthsClassified as death
Edwards SAPIEN 3 Transcatheter Heart valve8,1276689.2%
Evolut R Transcatheter Aortic Valve6,4445219.6%
Evolut Pro Plus Valve5,87378012.8%
Evolut Fx Valve5,26785114.1%
Evolut Pro Transcatheter Aortic Valve3,66842211%
Edwards SAPIEN 3 Ultra Transcatheter Heart Valve3,73771414%
Evolut Fx Plus Valve3,4482,3168.9%
Edwards COMMANDER DELIVERY SYSTEM3,10536812.3%
Edwards SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve2,8851,12811.6%
Evolut Fx Dcs2,57086010.8%
Edwards SAPIEN XT Transcatheter Heart Valve2,249487.6%
Navitor Vision2,0451,2586.4%
SAPIEN 3 Transcatheter Heart Valve2,1964196%
Corevalve Transcatheter Aortic Valve1,669609.6%
Edwards Sapien Transcatheter Heart Valve1,947714.3%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Edwards Lifesciences SAPIEN 3 Transcatheter Heart Valve reports

How many FDA reports name Edwards Lifesciences SAPIEN 3 Transcatheter Heart Valve?

266 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 132 in the latest 12 months.

What kinds of events are reported?

injury (93.2%), death (5.3%) and malfunction (1.5%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

calcified (29.3%), degraded (28.6%), device stenosis (14.3%), perivalvular leak (7.9%) and insufficient device problem information (6.8%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Edwards Lifesciences SAPIEN 3 Transcatheter Heart Valve was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.